Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation

Table 1 Summary of Zambia screening population (test set n = 998 and retraining/validation set n = 240)

	N (test set)	%	N (retraining/validation set)	%
HIV
HIV–	620	62	116	48
HIV+	354	35	122	51
Unknown	24	2	2	0.8
HPV
HPV 16+	88	9	54	23
HPV 18/45+	85	9	26	11
HPV 31/33/52/58+	126	13	34	14
HPV 35/39/51/56/59/66+	62	6	22	9
HPV HR negative	637	64	104	43
Histopathology result
No histology	759	76	128	53
Negative	88	9	17	7
CIN1	63	6	15	6
CIN2	16	2	11	5
CIN3	44	4	36	15
Squamous cancer	28	3	33	14
VIA
Negative	750	75	122	51
Positive	207	21	85	35
Cancer	41	4	33	14
AVE ground truth
Normal	550	55	80	33
Indeterminate	365	37	80	33
Precancer+	83	8	80	33

ISSN: 1750-9378